[Bucharest, 11 December 2023] – ZayaAI, a pioneering leader in the field of artificial intelligence, is thrilled to announce a strategic collaboration with Christophe Bourrilly, a longstanding financial advisor specialized in healthcare industry. Christophe joins ZayaAI as a member of its Board of Advisors, bringing a wealth of experience and expertise to the company.
Christophe Bourrilly, currently head of Kronos Advisors, the healthcare corporate finance advisory boutique and a shareholder in various healthcare companies, has a distinguished career spanning over two decades in various high-profile roles across Europe and the United States. His extensive experience in healthcare corporate finance, mergers & acquisitions, and strategic development will be invaluable to ZayaAI as it continues to grow and innovate in the AI industry.
Cristian Mogodici, CEO of ZayaAI: “We are honored to have Christophe join our team. His deep understanding of the financial landscape and experience in healthcare industry, financing and strategic growth will be critical as we continue to expand our reach and impact in the world of AI in digital pathology.”
Christophe Bourrilly, Member of ZayaAI Advisory Board: “I am delighted to be joining ZayaAI at this exciting time in their journey. The potential of AI in digital pathology is enormous, and ZayaAI has a unique blend of histopathology expertise, major tumor sample access, and world-class AI codes. I am looking forward to contributing to the company’s success and helping steer its strategic direction.”
ZayaAI is committed to revolutionizing digital pathology industry with its innovative AI solutions and is confident that Christophe’s guidance will greatly contribute to its mission. The company looks forward to leveraging his insights and expertise as it embarks on new ventures and continues to push the boundaries of what’s possible in AI.
About ZayaAI
ZayaAI equips pathologists and researchers in clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based ZayaAI products and services aim to improve the efficiency and precision of pathology diagnosis and pathology image analysis beyond current capabilities, across a variety of fields from oncology to dermato-pathology and more.